Symbravo
Payments companies reported to CMS as associated with Symbravo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Symbravo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Symbravo
These are the largest totals companies reported as associated with Symbravo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Eross | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $106,811.95 |
| Stewart Tepper | Stamford, CT | Neurology (Psychiatry & Neurology) | $85,259.88 |
| Christopher Rhyne | Louisville, KY | Family Medicine | $82,357.52 |
| Andrew Blumenfeld | Carlsbad, CA | Neurology (Psychiatry & Neurology) | $67,134.63 |
| Audrey Halpern | New York, NY | Neurology (Psychiatry & Neurology) | $47,842.16 |
| Pankaj Satija | Houston, TX | Neurology (Psychiatry & Neurology) | $47,523.73 |
| Justin Chandler | Danville, PA | Neurology (Psychiatry & Neurology) | $47,188.89 |
| Bradley Torphy | Chicago, IL | Family Medicine | $46,769.46 |
| Wade Cooper | Ann Arbor, MI | Neurology (Psychiatry & Neurology) | $45,210.32 |
| Jack Schim | Carlsbad, CA | Neurology (Psychiatry & Neurology) | $43,550.51 |
Prescribed Symbravo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.